| Authors: |
Waramit S; Cancer Phage Therapy, Department of Brain Sciences, Imperial, London, W12 0NN, UK; Department of Zoology, Faculty of Science, Kasetsart University, Bangkok, 10900, Thailand., Suwan K; Cancer Phage Therapy, Department of Brain Sciences, Imperial, London, W12 0NN, UK., Küçük A; Cancer Phage Therapy, Department of Brain Sciences, Imperial, London, W12 0NN, UK., Benjathummarak S; Center of Excellence for Antibody Research (CEAR), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Cencioni MT; Immunotherapy, Department of Brain Sciences, Imperial, London, W12 0NN, UK., Ashfield R; Department of Biochemistry, Department of Paediatrics and Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK., Gay L; Cancer Phage Therapy, Department of Brain Sciences, Imperial, London, W12 0NN, UK., Draper SJ; Department of Biochemistry, Department of Paediatrics and Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK., Hajitou A; Cancer Phage Therapy, Department of Brain Sciences, Imperial, London, W12 0NN, UK. Electronic address: a.hajitou@imperial.ac.uk. |
